Dual Anti-OX40/IL-2 Therapy Augments Tumor Immunotherapy via IL-2R-Mediated Regulation of OX40 Expression

Overview of attention for article published in PLOS ONE, April 2012

Altmetric Badge

Mentioned by

patent: 11 patents

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 11 patents that reference this research output.

Methods of administering anti-OX40 antibodies

Grant US-11472883-B2

United States of America

Antibodies and methods of use thereof

Grant US-11447557-B2

United States of America

Anti-OX40 antibodies and anti-GITR antibodies

Grant US-11359028-B2

United States of America

Vectors comprising nucleic acids encoding anti-OX40 antibodies

Grant US-11332536-B2

United States of America

BIFUNCTIONAL FUSION PROTEIN CONSISTING OF IL-2 AND ANTIBODY SUBUNIT

Application WO-2022089601-A1

World Intellectual Property Organisation (WIPO)

Anti-OX40 antibodies

Grant US-11136404-B2

United States of America

DUAL INTERLEUKIN-2 /TNF RECEPTOR AGONIST FOR USE IN THERAPY

Application WO-2021127262-A1

World Intellectual Property Organisation (WIPO)

Antibodies and methods of use thereof

Grant US-10836830-B2

United States of America

Nucleic acids encoding anti-OX40 antibodies

Grant US-10626181-B2

United States of America

Anti-OX40 antibodies

Grant US-10259882-B2

United States of America

DUAL OX40 AGONIST/IL-2 CANCER THERAPY METHODS

Application EP-2819693-A4

European Patent Office